US 11597773
CD6 antibody for treatment of T-cell mediated diseases or disorders
granted A61KA61K2039/505A61P
Quick answer
US patent 11597773 (CD6 antibody for treatment of T-cell mediated diseases or disorders) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Grant date
- Tue Mar 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/505, A61P, A61P37/06